Differential dopaminergic modulation of executive control in healthy subjects

Psychopharmacology

Volumn 178, Issue 4, 2005, Pages 420-430

  Roesch Ely, Daniela ^a   Scheffel, Hans ^a   Weiland, Stephan ^a   Schwaninger, Markus ^a   Hundemer, Hans Peter ^b   Kolter, Thomas ^b   Weisbrod, Matthias ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

Bromocriptine; D1 D2 dopamine receptors; Delayed response task; Dopamine agonists; Double blind clinical trial; Executive control; Inhibition of irrelevant information; Neuropsychology; Pergolide; Schizophrenia; Stroop; Working memory

Indexed keywords

BROMOCRIPTINE; BROMOCRIPTINE MESILATE; PERGOLIDE; PERGOLIDE MESILATE; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DRUG EFFECT; ERROR; FACILITATION; HEMISPHERIC DOMINANCE; HUMAN; HUMAN EXPERIMENT; INHIBITION KINETICS; MALE; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; REGULATORY MECHANISM; SCORING SYSTEM; TASK PERFORMANCE;

ADAPTATION, PSYCHOLOGICAL; ADMINISTRATION, ORAL; ADULT; AFFECT; BROMOCRIPTINE; CAPSULES; CROSS-OVER STUDIES; DOMPERIDONE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEEDBACK, PSYCHOLOGICAL; FUNCTIONAL LATERALITY; HAND; HUMANS; MALE; PERGOLIDE; PREFRONTAL CORTEX; REACTION TIME; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SOCIAL BEHAVIOR;

EID: 16844378973     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2027-z     Document Type: Article

References (58)

1. Aine CJ, Harter MR (1984) Hemispheric differences in event-related potentials to stroop stimuli. Attention and color-word processing. Ann NY Acad Sci 425:154-156
2. Arnsten AF (1997) Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 11:151-162
3. Arnsten AF, Cai JX, Murphy BL, Goldman-Rakic PS (1994) Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl) 116:143-151
4. Barch DM, Carter CS, Perlstein W, Baird J, Cohen JD, Schooler N (1999) Increased stroop facilitation effects in schizophrenia are not due to increased automatic spreading activation. Schizophr Res 39:51-64
5. Bartholomeusz CF, Box G, Van Rooy C, Nathan PJ (2003) The modulatory effects of dopamine D1 and D2 receptor function on object working memory in humans. J Psychopharmacol 17:9-15
6. Bliss EL, Ailion J (1971) Relationship of stress and activity to brain dopamine and homovanillic acid. Life Sci I 10:1161-1169
7. Brickenkamp R (1981) Test d2 Aufmerksamkeits-Belastungs-Test, 7th edn. Verlag für Psychologie (Hogrefe), Göttingen
8. Carter CS, Robertson LC, Nordahl TE (1992) Abnormal processing of irrelevant information in chronic schizophrenia: selective enhancement of Stroop facilitation. Psychiatry Res 41:137-146
9. Carter CS, Perlstein W, Ganguli R, Brar J, Mintun M, Cohen JD (1998) Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 155:1285-1287
10. Cohen JD, Servan-Schreiber D (1992) Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. Psychol Rev 99:45-77
11. Cooper JA, Sagar HJ, Doherty SM, Jordan N, Tidswell P, Sullivan EV (1992) Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. Brain 115:1701-1725
12. Daniel E, Weinberger D, Goldberg T et al (1991) Effect of amphetamine on regional blood flow during cognitive activation in schizophrenia. J Neurosci 11:1907-1917
13. Durstewitz D, Seamans JK, Sejnowski TJ (2000) Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. J Neurophysiol 83:1733-1750
14. Dyer F (1973) Stroop phenomenon and its use in the study of perceptual, cognitive, and response processes. Mem Cogn 1: 106-120
15. Fletcher PC, Frith CD, Grasby PM, Friston KJ, Dolan RJ (1996) Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia. J Neurosci 16:7055-7062
16. Goldberg TE, Egan MF, Gscheidle T et al (2003) Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 60:889-896
17. Gotham AM, Brown RG, Marsden CD (1988) "Frontal" cognitive function in patients with Parkinson's disease "on" and "off" levodopa. Brain 111:299-321
18. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153: 321-330
19. Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L (1994): Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11:245-256
20. Henik A, Singh J, Beckley D, Rafal R (1991) Disinhibition of automatic word reading in Parkinsons's disease. J Clin Exp Neuropsychol 14:81
21. Kimberg DY, D'Esposito M (2003) Cognitive effects of the dopamine receptor agonist pergolide. Neuropsychologia 41:1020-1027
22. Kimberg DY, D'Esposito M, Farah MJ (1997) Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 8:3581-3585
23. Kulisevsky J, Garcia-Sanchez C, Berthier ML et al (2000) Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients. Mov Disord 15:613-626
24. Larsson L-E, Agren G, Hughdahl K (1983) Outline and description of an electronic system for laterlaisation of visual stimuli in studies of hemispheric asymmetry. Scand J Psychol 24:267-275
25. Lehrl S (1977) Mehrfach-Wortschatz-Intelligenztest MWT-B. Straube, Erlangen
26. Levi-Minzi S, Bermanzohn PC, Siris SG (1991) Bromocriptine for "Negative Schizophrenia". Compr Psychiatry 32:210-216
27. Liddle PF, Morris DL (1991) Schizophrenie syndromes and frontal lobe performance. Br J Psychiatry 158:340-345
28. Lidow M, Goldman-Rakic P, Gallager D, Rakic P (1991) Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using (H3) raclopide, (H3) spiperone and (H3) SCH23390. Neuroscience 40:657-671
29. Luciana M, Collins PF (1997) Dopaminergic modulation of working memory for spatial but not for object cues in normal humans. J Cogn Neurosci 4:58-68
30. Luciana M, Depue RA, Arbisi P, Leon A (1992) Facilitation of working memory in humans by a D2 dopamine receptor agonist. J Cogn Neurosci 4:58-68
31. Mac Leod CM (1991) Half a century of research on the Stroop effect: an integrative review. Psychol Bull 109:163-203
32. Markela-Lerenc J, Ille N, Kaiser S, Fiedler P, Mundt C, Weisbrod M (2004) Prefrontal-cingulate activation during executive control: which comes first? Cogn Brain Res 18:278-287
33. Markham A, Benfield P (1997) Pergolide: a review of its pharmacology and therapeutic use in Parkinson's disease. CNS Drugs 7:328-340
34. McDowell S, Whyte J, D'Esposito M (1998) Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 121(Pt 6):1155-1164
35. Müller U, Yves D, Pollman S (1998) D1-versus D2-receptor modulation of visual spatial working memory in humans. J Neurosci 18:2720-2728
36. Norman DA, Shallice T (1986) Attention to action: willed and automatic control of behavior. In: Davidson RJ, Schwartz GE, Shapiro D (eds). Consciousness and self-regulation. Plenum, New York, pp 1-18
37. Oertel W, Quinn N (1996) Parkinsonism. In: Brandt T, Caplan L, Dichgans J, Diener H, Kennard C (eds) Neurological disorders: course and treatment. Academic, San Diego, pp 715-772
38. Ohmori T, Koyama T, Inoue T, Matsubara S, Yamashita I (1993) B-HT 920, a dopamine D2 agonist, in the treatment of negative symptoms of chronic schizophrenia. Biol Psychiatry 33: 687-693
39. Oldfield R (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97-113
40. Owen AM, Beksinska M, James M, Lange KW, Summers BA, Leigh PN (1991) Dopamine dependent spatial working memory deficits in Parkinson's disease. Soc Neurosci Abstr 17:1261
41. Pillon B, Gouider-Khouja N, Deweer B et al (1995) Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 58:174-191
42. Robbins TW (2000) Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp Brain Res 133: 130-138
43. Roesch-Ely D (2002) Normal and disordered thought in schizophrenia. Dissertation, Experimental Psychopathology, Heidelberg
44. Royall DR, Lauterbach EC, Cummings JL et al (2002) Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 14:377-405
45. Sawaguchi T, Goldman-Rakic PS (1991) D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251:947-950
46. Schmit V, Davis R (1974) The role of hemispheric specialization in the analysis of Stroop stimuli. Acta Psycologica 38:149-158
47. Schultz W, Apicella P, Ljungberg T (1993) Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurosci 13:900-913
48. Seamans JK, Gorelova N, Durstewitz D, Yang CR (2001) Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 21:3628-3638
49. Spitzer M (1993) The psychopathology, neuropsychology, and neurobiology of associative and working memory in schizophrenia. Eur Arch Psychiatry Clin Neurosci 243:5-70
50. Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643-662
51. Tsao Y, Feustel T, Soseos C (1979) Stroop interference in the right and left visual fields. Brain Lang 8:367-371
52. Tzschentke TM (2001) Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 63:241-320
53. Velhagen K, Broschmami D (1995) Tafeln zur Prüfung des Farbensinnes, 30th edn. Georg Thieme, Stuttgart
54. Wachtel H (1991) Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans. J Neural Transm Park Dis Dement Sect 3:151-201
55. Weinberger DR (2003) Dopamine, the prefrontal cortex, and a genetic mechanism of schizophrenia. In: Lecrubier Y and Kapur S (eds) Dopamine in the pathophysiology and treatment of schizophrenia. Martin Dunitz, London, pp 129-154
56. Williams G, Goldman-Rakic P (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376: 549-550
57. World Health Organisation, Health DoM (1992) Schedules for Clinical Assessment in Neuopsychiatry, SCAN
58. van Zerssen D, Koeller DM (1976) Befindlichkeitsskala (Bf-S). Beltz, Weinheim